Cross-talk between Remodeling and de Novo Pathways Maintains Phospholipid Balance through Ubiquitination
被引:32
作者:
Butler, Phillip L.
论文数: 0引用数: 0
h-index: 0
机构:Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA
Butler, Phillip L.
Mallampalli, Rama K.
论文数: 0引用数: 0
h-index: 0
机构:
Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA
Univ Pittsburgh, Dept Internal Med, Pittsburgh, PA 15213 USAVet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA
Mallampalli, Rama K.
[1
,2
]
机构:
[1] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA
[2] Univ Pittsburgh, Dept Internal Med, Pittsburgh, PA 15213 USA
Phosphatidylcholine (PtdCho), the major phospholipid of animal membranes, is generated by its remodeling and de novo synthesis. Overexpression of the remodeling enzyme, LPCAT1 (acyl-CoA: lysophosphatidylcholine acyltransferase) in epithelia decreased de novo PtdCho synthesis without significantly altering cellular PtdCho mass. Overexpression of LPCAT1 increased degradation of CPT1 (cholinephosphotransferase), a resident Golgi enzyme that catalyzes the terminal step for de novo PtdCho synthesis. CPT1 degradation involved its multiubiquitination and processing via the lysosomal pathway. CPT1 mutants harboring arginine substitutions at multiple carboxyl-terminal lysines exhibited proteolytic resistance to effects of LPCAT1 overexpression in cells and restored de novo PtdCho synthesis. Thus, cross-talk between phospholipid remodeling and de novo pathways involves ubiquitin-lysosomal processing of a key molecular target that mechanistically provides homeostatic control of cellular PtdCho content.